Time course of in vivo 5-HTT transporter occupancy by fluvoxamine

Journal of Clinical Psychopharmacology

Volumn 26, Issue 2, 2006, Pages 188-191

  Takano, Akihiro ^a,b   Suhara, Tetsuya ^a,b   Ichimiya, Tetsuya ^a,b   Yasuno, Fumihiko ^a,b   Suzuki, Kazutoshi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 4 (2 DIMETHYLAMINOMETHYLPHENYLSULFANYL)BENZONITRILE C 11; CARBON 11; FLUVOXAMINE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; CLINICAL ARTICLE; CORPUS STRIATUM; DRUG BRAIN LEVEL; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THALAMUS;

ADULT; ANILINE COMPOUNDS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRAIN; CARBON RADIOISOTOPES; FLUVOXAMINE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SULFIDES;

EID: 33646684492     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000203201.34323.d3     Document Type: Article

References (13)

1. Owens MJ, Morgan WN, Plott SJ, et al. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther. 1997;283:1305-1322.
2. Suhara T, Takano A, Sudo Y, et al. High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. Arch Gen Psychiatry. 2003;60:386-391.
3. 11C]DASB positron emission tomography study. Am J Psychiatry. 2004;161:826-835.
4. 11C]DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. Synapse. 2003;47:123-133.
5. 11C-labeled 2-(phenylthio)araalkylamines. J Med Chem. 2000;43:3103-3110.
6. Yasuno F, Hasnine AH, Suhara T, et al. Template-based method for multiple volumes of interest of human brain PET images. Neuroimage. 2002;16:577-586.
7. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003;23:1096-1112.
8. 19F magnetic resonance spectroscopy. Am J Psychiatry. 1998;155:380-384.
9. Takano A, Suhara T. The necessary parameters for estimating the time course of receptor occupancy. Int J Neuropsychopharmacol. 2005;8:143-144.
10. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999;19:67-85.
11. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol. 1996;16:356-362.
12. Rosenbaum JF, Fava M, Hoog SL, et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998;44:77-87.
13. 11C]DASB in healthy humans: comparison of methods. Proceedings of the Society of Nuclear Medicine 50th Annual Meeting; 2003; New Orleans, LA.